Abstract
Cerebral malaria (CM) is characterized by a dysregulated immune response that results in endothelial membrane destabilization and increased microparticle (MP) production. Citicoline (CTC) is a membrane stabilizer used for the treatment of neurological disorders. We evaluated the efficacy of CTC as adjunct therapy to aid recovery from experimental CM. We show that CTC reduces MP production in vitro; in combination with artesunate in vivo, confers partial protection against CM; and prolongs survival. © 2014, American Society for Microbiology. All Rights Reserved.
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Cite
CITATION STYLE
El-Assaad, F., Combes, V., Raymond Grau, G. E., & Jamboua, R. (2014). Potential Efficacy of Citicoline as Adjunct Therapy in Treatment of Cerebral Malaria. Antimicrobial Agents and Chemotherapy, 58(1), 602–605. https://doi.org/10.1128/AAC.02591-12
Readers over time
Readers' Seniority
Readers' Discipline
